Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.37% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Mar 31, 2014
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001087294-14-000021General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.14% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-21.10% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
91.71% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
86.98% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
5.04% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.21% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.55% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.30%
- Current
- 0.37%
- Delta
- 0.06%
- Previous
- 2.33%
- Current
- 12.14%
- Delta
- 9.81%
- Previous
- -34.44%
- Current
- -21.10%
- Delta
- 13.33%
- Previous
- 17.87%
- Current
- 91.71%
- Delta
- 73.84%
- Previous
- 83.02%
- Current
- 86.98%
- Delta
- 3.96%
- Previous
- -11.87%
- Current
- 5.04%
- Delta
- 16.91%
- Previous
- 17.53%
- Current
- 10.21%
- Delta
- -7.32%
- Previous
- 2.11%
- Current
- 1.55%
- Delta
- -0.55%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Has State · CUMBERLAND PHARMACEUTICALS INC →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_INCREASED →Transitioned To · CPIX CASH_GENERATION_INCREASED →Transitioned To · CPIX GROWTH_INCREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_DECREASED →Transitioned To · CPIX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.